These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17339006

  • 1. A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
    McLachlan CS, Zhang Z, Mossop P.
    J Card Fail; 2007 Feb; 13(1):75-6. PubMed ID: 17339006
    [No Abstract] [Full Text] [Related]

  • 2. Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.
    Meune C, Wahbi K, Fulla Y, Cohen-Solal A, Duboc D, Mahé I, Simoneau G, Bergmann JF, Weber S, Mouly S.
    Eur J Heart Fail; 2007 Feb; 9(2):197-201. PubMed ID: 16914369
    [Abstract] [Full Text] [Related]

  • 3. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial.
    Lainchbury JG, Troughton RW, Frampton CM, Yandle TG, Hamid A, Nicholls MG, Richards AM.
    Eur J Heart Fail; 2006 Aug; 8(5):532-8. PubMed ID: 16829189
    [Abstract] [Full Text] [Related]

  • 4. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J, Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators.
    Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
    [Abstract] [Full Text] [Related]

  • 5. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract] [Full Text] [Related]

  • 6. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW, Howlett JG.
    Heart Fail Monit; 2007 Nov 20; 5(3):70-6. PubMed ID: 17487295
    [Abstract] [Full Text] [Related]

  • 7. [Interaction of angiotensin-converting enzyme inhibitors with aspirin].
    Agustí A, Diògene E.
    Med Clin (Barc); 2003 Nov 08; 121(16):631-3. PubMed ID: 14636540
    [No Abstract] [Full Text] [Related]

  • 8. BNP or NTproBNP? A clinician's perspective.
    Steiner J, Guglin M.
    Int J Cardiol; 2008 Sep 16; 129(1):5-14. PubMed ID: 18378336
    [Abstract] [Full Text] [Related]

  • 9. Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
    Ibrahim A, Baibars M, Alraies MC, Oliveira GH.
    Cleve Clin J Med; 2012 Jan 16; 79(1):22-5. PubMed ID: 22219230
    [No Abstract] [Full Text] [Related]

  • 10. The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?
    Moskowitz R.
    Curr Cardiol Rep; 2001 May 16; 3(3):247-53. PubMed ID: 11305980
    [Abstract] [Full Text] [Related]

  • 11. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB, Barrett-Connor E.
    J Am Coll Cardiol; 2009 Nov 10; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract] [Full Text] [Related]

  • 12. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
    Cleland JG, Squire I, Ng L.
    J Am Coll Cardiol; 2008 Sep 23; 52(13):1104-5. PubMed ID: 18848145
    [No Abstract] [Full Text] [Related]

  • 13. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL, Bayes-Genis A.
    Drug News Perspect; 2009 Jun 23; 22(5):267-73. PubMed ID: 19609464
    [Abstract] [Full Text] [Related]

  • 14. [Drug interactions in therapy of cardiac decompensation].
    G Ital Cardiol; 1994 Oct 23; 24(10):1285-8. PubMed ID: 7835557
    [No Abstract] [Full Text] [Related]

  • 15. B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure.
    Moertl D, Berger R, Hammer A, Huelsmann M, Hutuleac R, Pacher R.
    J Card Fail; 2009 Apr 23; 15(3):233-40. PubMed ID: 19327625
    [Abstract] [Full Text] [Related]

  • 16. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.
    Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088
    [Abstract] [Full Text] [Related]

  • 17. Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure.
    Di Somma S, Magrini L, Mazzone M, De Leva R, Tabacco F, Marino R, Talucci V, Ferri E, Forte P, Cardelli P, Gentiloni N, Pittoni V.
    Am J Emerg Med; 2007 Mar 15; 25(3):335-9. PubMed ID: 17349910
    [Abstract] [Full Text] [Related]

  • 18. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?
    Maisel A.
    J Am Coll Cardiol; 2009 Dec 29; 55(1):61-4. PubMed ID: 20117365
    [No Abstract] [Full Text] [Related]

  • 19. Understanding ACE inhibitors.
    Wilson BA.
    Medsurg Nurs; 1995 Feb 29; 4(1):62-4. PubMed ID: 7874224
    [No Abstract] [Full Text] [Related]

  • 20. [Aspirin-ACE inhibitors interaction: myth or reality?].
    Meune C, Mourad JJ.
    J Mal Vasc; 2001 Dec 29; 26(5):284-6. PubMed ID: 11917659
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.